The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of early-line nab-paclitaxel (nab-P) versus eribulin in patients (pts) with metastatic breast cancer (MBC): A U.S. real-world analysis.
 
Fadi S. Braiteh
Employment - US Oncology
Honoraria - Amgen; BIND Therapeutics; Boehringer Ingelheim; Caris Life Sciences; Dendreon; Foundation Medicine; Incyte; Insys Therapeutics; MolecularHealth; Novartis; Pfizer; Salarius Pharmaceuticals; Sanofi
Consulting or Advisory Role - Amgen; BIND Therapeutics; Boehringer Ingelheim; Caris Life Sciences; Dendreon; Foundation Medicine; Incyte; Insys Therapeutics; MolecularHealth; Novartis; Pfizer; Saladax Biomedical; Sanofi
Speakers' Bureau - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Genomic Health; Incyte; Insys Therapeutics; MolecularHealth; Novartis; Pfizer; Saladax Biomedical; Sanofi
Research Funding - Abbvie; Active Biotech; Amgen; AstraZeneca/MedImmune; Bayer; BIND Therapeutics; Biomarin; bioTheranostics; BN ImmunoTherapeutics; Boston Biomedical; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Cell Therapeutics; Daiichi Sankyo; Dendreon; Endocyte; Exelixis; Foundation Medicine; Genomic Health; Gilead Sciences; GlaxoSmithKline; Halozyme; HERON; ImClone Systems; Incyte; Insys Therapeutics; Janssen; Lilly; MEI Pharma; Merrimack; Millennium; MolecularHealth; Novartis; Pfizer; Pharmacyclics; Plexxikon; PSMA Development Company; Roche/Genentech; Saladax Biomedical; Sanofi; Seagen; Viamet Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Foundation Medicine; Genomic Health; Gilead Sciences; HERON; Incyte; Insys Therapeutics; Lilly; MolecularHealth; Pfizer; Roche/Genentech; Saladax Biomedical; Sanofi
 
Monika Parisi
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Quanhong Ni
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Si yeon Park
Employment - Celgene
 
Claudio Faria
Employment - Celgene
Stock and Other Ownership Interests - Celgene